Liquid Biopsy
80 Employers in 109 locations
80 Employers in 109 locations
Employers working on Liquid Biopsy work in 38 other areas
Displaying 1 - 15 of 38 related areas- Cancer Diagnostics (24)
- Cancer (7)
- Diagnostics (6)
- Molecular Diagnostics (6)
- COVID-19 (5)
- Artificial Intelligence (4)
- RNA (4)
- DNA Methylation (3)
- DNA Sequencing (3)
- Epigenetics (3)
- Antibodies (2)
- Cardiovascular (2)
- Colorectal Cancer (2)
- Proteins and Proteomics (2)
Displaying 1 - 60 of 80 employers
Only three business areas are listed for each employer.Business Area(s)
Description
4D Lifetec has developed a non-genomic liquid biopsy assay for multiple cancer ...
Business Area(s)
Description
Acuamark Diagnostics develops technology which allows for highly accurate ...
Business Area(s)
Description
Adela’s technology distinguishes the most-highly informative (methylated) ...
Business Area(s)
Description
Developing al blood test to measure cancer and cancer treatment effectiveness
Business Area(s)
Description
Developing sensitive protein detection technologies for cancer diagnostics.
Business Area(s)
Description
Amoy Diagnostics Co., Ltd. (AmoyDx) focuses on molecular diagnostics for ...
Business Area(s)
Description
Anpac Bio’s CDA technology combines an assessment of existing biomarkers with ...
Business Area(s)
Description
Aqtual discovered a way to measure epigenetics, gene regulation, and ...
Business Area(s)
Description
ARNA Genomics US Inc. (USA), created to develop fluid biopsy technologies.
Business Area(s)
Description
BioCaptiva is developing BIOCAPTOR, a revolutionary medical device that will ...
Business Area(s)
Description
The heart of BioFluidica's CTC (Circulating Tumor Cells) system, is a highly ...
Business Area(s)
Description
BioMark is an oncology-focused company with advanced near-to- market liquid ...
Business Area(s)
Description
C2i Genomics offers post-surgery monitoring of cancer recurrence and progression ...
Business Area(s)
Description
CelLBxHealth (formerly ANGLE plc) is a specialized liquid biopsy company focused ...
Business Area(s)
Description
CellMax uses saliva and/or blood samples to identify risks for hereditary ...
Business Area(s)
Description
Cellsway, established in 2020, focuses on development of microfluidics and lab ...
Business Area(s)
Description
Celsee’s C-Prep platforms are nanofluidic chips containing tens of thousands to ...
Business Area(s)
Description
Circulogene's “liquid biopsy” is based on the discovery that as tumors grow ...
Business Area(s)
Description
Convergent Genomics is developing liquid biopsy and next-generation sequencing ...
Business Area(s)
Description
Creatv MicroTech, Inc. is a privately held company with expertise in diagnostics ...
Business Area(s)
Description
Cyclomics is a Dutch startup company founded in 2018 by scientists of the UMC ...
Business Area(s)
Description
Developing test for early cancer detection.
Business Area(s)
Description
Droplet has pioneered a platform to harvest and profile patient lymph through ...
Business Area(s)
Description
A drop of blood serum is dried on a Dxcover® Slide and analyzed with infrared ...
Business Area(s)
Description
Develops cancer diagnostic tests, initially colorectal cancer screening. Acuired ...
Business Area(s)
Description
Orphan non-coding RNAs (oncRNAs) are only observed in cancer and diseased ...
Business Area(s)
Description
Developing RNA based liquid biopsy. Circulating RNA analysis have the potential ...
Business Area(s)
Description
Developubg a liquid biopsy minimal residual disease (MRD) test that detects ...
Business Area(s)
Description
Develop liquid biopsy for minimal residual disease (MRD) detection to measure ...
Business Area(s)
Description
Provides DNA sequencing services for liquid biopsy in detecting cancer and ...
Business Area(s)
Description
Develops SILVER-Seq™ ( Small Input Liquid Volume Extracellular RNA Sequencing) ...
Business Area(s)
Description
Developing liquid biopsy tests using Next Gen Sequencing (NGS).
Business Area(s)
Business Area(s)
Description
The company makes blood tests that can be used to detect cancer and mutations in ...
Business Area(s)
Description
Tumor Liquid Biopsy with Ultra-micro DNA
Business Area(s)
Description
Haystack Oncology uses the next generation of circulating tumor DNA (ctDNA) ...
Business Area(s)
Description
Hedera Dx’s liquid biopsy solution for in-hospital tumor profiling.
Business Area(s)
Description
Helio Genomics has developed a proprietary platform called ECLIPSE, which allows ...
Business Area(s)
Description
Hummingbird Diagnostics is developing liquid biopsy diagnostics for early ...
Business Area(s)
Description
Developing technology for profiling tumors in blood.
Business Area(s)
Description
Immunis.AI is a privately held immunogenomic ‘liquid biopsy’ platform company ...
Business Area(s)
Description
IV Bioholdings focuses on developing liquid biospy companies.
Business Area(s)
Description
Development an array-based platform for a liquid biopsy-based test that can ...
Business Area(s)
Description
The Karius test harnesses next-generation sequencing to detect fragments of cell ...
Business Area(s)
Description
The company uses genetics for better diagnostics, better decisions, and better ...
Business Area(s)
Description
LuminoDx Inc. is focused on advancing precision medicine through next-generation ...
Business Area(s)
Description
The mDETECT assay monitors tumor burden in patients with all subtypes of Breast ...
Business Area(s)
Description
Israeli health technology company developing liquid biopsy tests for the early ...
Business Area(s)
Description
MiCareo is developing liquid biopsy technologies that provide high purity ...
Business Area(s)
Description
Mirnax Biosens, S.L. is a biotechnology company, owned by Canaan Research & ...
Business Area(s)
Description
miRNA is widely recognized as a promising biomarker for disease diagnostics ...
Business Area(s)
Description
Molecular Stethoscope is developing a platform to detect circulating mRNA. mRNA ...
Business Area(s)
Description
Provide a variety of cell free DNA (cfDNA) analysis solutions.
Business Area(s)
Description
Nucleix has developed a method to read DNA Methylation changes.
Business Area(s)
Description
Oxford Cancer Analytics is identifying curative cancer treatments through a ...
Business Area(s)
Description
Personal Genome Diagnostics (PGDx) is empowering the fight against cancer by ...
Business Area(s)
Description
Pillar Biosciences was founded on the belief that one day we can bring the ...
Business Area(s)
Description
The PlaqueTec Liquid Biopsy System™ (LBS™) is a specialised catheter that ...